FID-007 in Treating Participants With Advanced Solid Tumors

Conditions:   Advanced Malignant Solid Neoplasm;   Refractory Malignant Solid Neoplasm Interventions:   Other: Laboratory Biomarker Analysis;   Drug: PEOX-based Polymer Encapsulated Paclitaxel FID-007;   Other: Pharmacokinetic Study Sponsors:   University of Southern California;   National Cancer Institute (NCI) Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials